Joel Gallant

2PUBLICATIONS
0CO-AUTHORS
Gene and molecular therapyLife histories
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 09, 2022
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people ≥65 years of age.

Franco Maggiolo, Giuliano Rizzardini, Jean-Michel Molina

|Mar 09, 2021
Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial.

Franco Maggiolo, Giuliano Rizzardini, Jean-Michel Molina

Pageof 1

Frequent Collaborators